SEC Form 4 · accession 0001209191-17-017003
CYPRESS SEMICONDUCTOR CORP /DE/ · CY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dana Nazarian
Officer — EVP, Operations & Technology
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 8:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000791915
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 28, 2017 | M | 61,920 | $0.00 | A | 570,291 | D | |
| Common StockF3,F2 | Feb 28, 2017 | M | 25,850 | $0.00 | A | 596,141 | D | |
| Common StockF4 | Mar 1, 2017 | F | 45,838 | $13.2857 | D | 550,303 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the March 3, 2015 grant awarded under the Issuer's 2013 Stock Plan (the "Stock Plan") as part of the Issuer's Performance Based Accelerated Restricted Stock Program (the "PARS Program").
- F2Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant.
- F3Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the April 1, 2016 grant awarded under the Issuer's Stock Plan as part of the Issuer's PARS Program.
- F4The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.28 to $13.3 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.